Dare Bioscience, Inc.DARE

Market cap

$331.17M

P/E ratio

	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022
Cash and cash equivalents	51	76	35	8	7	5	5	52	35
Other receivables	-	-	-	284,206	31,037	555,210	460,168	1	2
Prepaid expenses	-	-	-	311,571	403,097	1	2	2	7
Total current assets	53	77	37	8	7	6	7	55	43
Property and equipment, net	0	1	1	-	9,396	63,531	37,930	26,041	64,908
Other non-current assets	0	0	0	723,191	577,968	935,325	528,870	485,120	722,722
Total assets	53	78	38	14	8	7	8	56	44
Accounts payable	1	2	1	-	459,705	1	1	2	2
Accrued expenses	4	6	5	-	631,351	2	3	3	11
Deferred grant funding	-	-	-	-	-	2	2	11	18
Operating Lease, Liability, Current	-	-	-	-	-	0	347,712	0	0
Total current liabilities	8	16	17	966,653	1	6	8	16	32
Deferred license revenue	-	-	-	-	-	-	1,000,000	1,000,000	1,000,000
Lease liabilities long-term	-	-	-	-	-	-	-	-	0
Total liabilities	-	-	-	967,045	1	7	9	17	33
Preferred stock issued	-	-	-	-	-	-	-	-	-
Common Stock, Value, Issued	0	0	0	605	1,143	1,968	4,159	8,394	8,482
Accumulated other comprehensive loss	-	-	-	-18,080	-96,728	-102,625	-91,388	-154,973	-351,311
Additional paid-in capital	-	210	214	26	36	45	70	149	153
Accumulated deficit	-122	-161	-201	-12,230,952	-28,969,767	-44,023,191	-71	-110	-141
Total stockholders' equity	45	49	13	13	7	440,826	-1,151,733	39	11
Total liabilities and stockholders' equity	53	78	38	14	8	7	8	56	44